PACIRA PHARMACEUTICALS INC's ticker is and the CUSIP is 695127AB6. A total of 15 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $30,494,000 | -7.0% | 21,743,000 | 0.0% | 0.39% | -19.6% |
| Q3 2016 | $32,797,000 | +1.1% | 21,743,000 | 0.0% | 0.49% | -0.6% |
| Q2 2016 | $32,454,000 | -32.4% | 21,743,000 | 0.0% | 0.49% | -63.9% |
| Q1 2016 | $48,012,000 | -29.2% | 21,743,000 | 0.0% | 1.36% | -6.5% |
| Q4 2015 | $67,784,000 | +81.7% | 21,743,000 | +1.6% | 1.46% | +65.9% |
| Q3 2015 | $37,296,000 | -38.7% | 21,393,000 | 0.0% | 0.88% | -36.3% |
| Q2 2015 | $60,869,000 | -20.1% | 21,393,000 | +0.5% | 1.38% | -9.1% |
| Q1 2015 | $76,203,000 | -0.1% | 21,293,000 | 0.0% | 1.52% | +2.4% |
| Q4 2014 | $76,258,000 | -9.1% | 21,293,000 | -0.5% | 1.48% | -15.2% |
| Q3 2014 | $83,860,000 | +5.1% | 21,393,000 | 0.0% | 1.75% | +0.2% |
| Q2 2014 | $79,773,000 | – | 21,393,000 | – | 1.75% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EQUITEC SPECIALISTS, LLC | 3,000,000 | $4,524,000 | 1.31% |
| Myriad Asset Management Ltd. | 10,000,000 | $14,880,000 | 0.95% |
| WHITEBOX ADVISORS LLC | 11,350,000 | $17,117,000 | 0.71% |
| WOLVERINE ASSET MANAGEMENT LLC | 21,743,000 | $32,797,000 | 0.49% |
| MIZUHO SECURITIES USA LLC | 3,500,000 | $5,275,000 | 0.44% |
| Verition Fund Management LLC | 1,160,000 | $1,755,000 | 0.19% |
| CSS LLC/IL | 1,500,000 | $2,245,000 | 0.11% |
| PALISADE CAPITAL MANAGEMENT, LP | 982,000 | $1,473,000 | 0.05% |
| Citadel Advisors | 30,050,000 | $45,358,000 | 0.05% |
| LAZARD ASSET MANAGEMENT LLC | 9,000,000 | $13,618,000 | 0.03% |